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Abstract
Objectives The clinical applicability of magnetic resonance image−guided high-intensity focused ultrasound (MR-HIFU) treat-
ment of uterine fibroids is often limited due to inaccessible fibroids or bowel interference. The aim of this study was to implement
a newly developed 3-step modified manipulation protocol and to evaluate its influence on the number of eligible women and
treatment failure rate.
Methods From June 2016 to June 2018, 165 women underwent a screening MRI examination, 67 women of whom were
consecutively treated with MR-HIFU at our institution. Group 1 (n = 20) was treated with the BRB manipulation protocol which
consisted of sequential applications of urinary bladder filling, rectal filling, and urinary bladder emptying. Group 2 (n = 47) was
treated using the 3-step modified manipulation protocol which included (1) the BRB maneuver with adjusted rectal filling by
adding psyllium fibers to the solution; (2) Trendelenburg position combined with bowel massage; (3) the manual uterine
manipulation (MUM) method for uterine repositioning. A comparison was made between the two manipulation protocols to
evaluate differences in safety, the eligibility percentage, and treatment failure rate due to unsuccessful manipulation.
Results After implementing the 3-step modified manipulation protocol, our ineligibility rate due to bowel interference or inac-
cessible fibroids decreased from 18% (16/88) to 0% (0/77). Our treatment failure rate due to unsuccessful manipulation decreased
from 20% (4/20) to 2% (1/47). There were no thermal complications to the bowel or uterus.
Conclusions Implementation of the 3-step modified manipulation protocol during MR-HIFU therapy of uterine fibroids im-
proved the eligibility percentage and reduced the treatment failure rate.
Trial registration Registry number NL56182.075.16
Key Points
• A newly developed 3-step modified manipulation protocol was successfully implemented without the occurrence of thermal
complication to the bowel or uterus.
• The 3-step modified manipulation protocol increased our eligibility percentage for MR-HIFU treatment of uterine fibroids.
• The 3-step modified manipulation protocol reduced our treatment failure rate for MR-HIFU treatment of uterine fibroids.
Keywords Uterine fibroids .MR-guided interventional procedures .High-intensity focusedultrasoundablation . Patient selection
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Abbreviations
BRB Bladder filling, rectal filling, bladder emptying
CE Contrast-enhanced
MR-HIFU Magnetic resonance image–guided high-
intensity focused ultrasound
MRI Magnetic resonance imaging
MUM Manual uterine manipulation
NPV Non-perfused volume
SI Signal intensity
Introduction
Magnetic resonance image–guided high-intensity focused ul-
trasound (MR-HIFU) has been a treatment option for uterine
fibroids since 2004. MR-HIFU has been proven to be safe and
effective in reducing fibroid-related symptoms and fibroid
size [1, 2]. Although the treatment has emerged as the only
non-invasive interventional therapy, MR-HIFU has not been
widely adopted into regular care up to now. It seems plausible
that a combination of factors is responsible for this such as
technical limitations and clinical availability, and also famil-
iarity of the gynecologist with such expertise. Technical lim-
itations of MR-HIFU treatment include the duration of the
treatment, the focal depth and maximum power of the HIFU
system, and the relatively low eligibility percentage compared
with hysterectomy and embolization [3, 4]. The number of
referred patients with fibroids suitable for MR-HIFU therapy
in previously reported studies ranged from 14 to 74% depend-
ing on the used selection guidelines [5–7]. A screening MRI
examination is performed to assess technical eligibility, but it
remains difficult to predict MR-HIFU treatment outcome
based on imaging characteristics. Moreover, even when eligi-
ble patients undergo MR-HIFU therapy, the risk for an unsuc-
cessful treatment persists. A frequent reason for ineligibility
and failure ofMR-HIFU therapy was the interposition of bow-
el loops in the acoustic pathway [8, 9]. Interestingly, it was
reported that interposed bowel loops occurred in the expected
sonication path on the treatment day while there was no inter-
position present on the screening MRI examination [10]. This
finding suggested a reversible situation; therefore, manipula-
tion techniques have been widely implemented. The most
common technique to displace bowel loops was described
by Park et al This technique includes sequential applications
of urinary bladder filling, rectal filling, and bladder emptying,
which is also referred to as the BRBmaneuver [10]. However,
the problem of bowel interference can still persist when the
BRB maneuver fails. In our center, a newly developed manip-
ulation protocol was implemented which consisted of three
different manipulation techniques. This gave us the opportu-
nity to evaluate the difference between two manipulation pro-
tocols with respect to the eligibility percentage and treatment
failure rate due to unsuccessful manipulation.
Material and methods
This prospective single-center study was conducted from
June 2016 to June 2018. This study (registry number
NL56182.075.16) was approved by our local Research
Ethics Committee (number 16.0479). Information about the
medical history of patients was retrieved from medical re-
cords. Informed consent was obtained from all patients.
Patients
All women presenting with fibroid-related symptoms at the
gynecology outpatient clinic were evaluated for inclusion.
Eligible patients were offered to undergo anMRI examination
and their symptom severity and quality of life were assessed
with a validated disease-specific questionnaire [11]. Inclusion
criteria were uterine fibroids confirmed on ultrasound, age
over 18 years, and pre- or peri-menopausal state. Exclusion
criteria were as follows: pregnancy, calcification of the uterine
fibroid, severe obesity, or MRI contraindications including
contrast allergy. These inclusion and exclusion criteria
remained the same, independent of the used manipulation
protocol.
Screening MRI examination
The screening MRI protocol to assess patient suitability for
MR-HIFU treatment consisted of three-dimensional (3D) T2-
weighted imaging and contrast-enhanced (CE) T1-weighted
imaging immediately after administration of a contrast agent
(DOTAREM®, 0.2 mL/kg; gadoterate meglumine, 0.1 mmol/
kg). All MRI examinations were evaluated by radiologists
with MR-HIFU experience. The position of the uterus, the
number of fibroids, fibroid location, the presence of bowel
interference, and abdominal scar tissue were reported. One
researcher (I.V.) performed all measurements on the screening
MRI examination: the thickness of the subcutaneous abdom-
inal fat layer, maximum diameter, and fibroid volume by
semi-automatic segmentation in IntelliSpace Portal (ISP) soft-
ware (Philips Healthcare). Signal intensity (SI) of the fibroid
on T2-weighted (T2w) images was compared to the SI of the
rectus abdominis muscle and the myometrium, and the fibroid
was classified according to the Funaki classification [12].
Patient selection for MR-HIFU
Potentially eligible patients for MR-HIFU therapy were select-
ed based on the screening MRI. Exclusion criteria for MR-
HIFU included current pregnancy, fat layer < 4 cm, concomi-
tant adenomyosis, suspicion of malignancy on screening MRI,
no contrast-enhancement of the targeted fibroid on the T1-
weighted (T1w) image, maximum diameter of the dominant
fibroid < 1 cm, > 10 uterine fibroids (without one or two large
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dominant fibroids explaining the clinical symptoms of the pa-
tient), excessively high T2 signal of the targeted fibroid com-
pared with the myometrium on the T2w image, or an inacces-
sible targeted uterine fibroid (despite the use of manipulation
techniques, the depth of the posterior wall of the targeted uter-
ine fibroid will be > 10 cm from the abdominal wall).
The choice to undergo MR-HIFU therapy was based on
patient preference. In total, 165 women consecutively
underwent a screening MRI examination during the study
period, of which 99 patients seemed eligible and 67 women
were consecutively treated with MR-HIFU (Fig. 1). To eval-
uate the influence of the used manipulation protocol on the
eligibility percentage and treatment failure rate, two study
cohorts were compared (Fig. 1). In group A, 88 women were
screened, of which 41 seemed eligible and 20 patients consec-
utively underwent MR-HIFU therapy (group 1). If indicated,
these first 20 patients received manipulation techniques ac-
cording to protocol 1. In group B, 77 women were screened,
of which 58 seemed eligible and 47 patients consecutively
underwent MR-HIFU therapy (group 2). If indicated, these
last 47 patients received manipulation techniques according
to protocol 2.
Patient preparation
Pre-operative evaluation was performed before the MR-HIFU
procedure for anesthetic risk assessment. All patients fasted
6 h prior to therapy and were asked to shave their lower ab-
domen and pubic region. Patient preparation was performed at
the nursing department. Bowel preparation was done using a
fast-acting Microlax micro-enema. A single-dose (1 tube of
5 mL) was administered rectally. Patients received oral
premedication which included paracetamol 1000 mg,
diclofenac 100 mg, and oxycodone 10 mg. A Foley catheter
and intravenous line were inserted directly before treatment.
Fig. 1 Flow diagram
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Manipulation techniques
When required, manipulation techniques were applied to achieve
the optimal position of the targeted uterine fibroid to allow for
complete ablation. The optimal position was defined as follows:
targeted uterine fibroid being entirely accessible by the system
without interposition of critical structures in the near and far
fields of the beam pathway. At the start of the MR-HIFU treat-
ment, patients were placed into prone position on the MRI table.
A gel pad and degassedwater were used for acoustic coupling. A
survey MR image and T2w 3D planning images were obtained
to reassess the location of the uterine fibroid. None of the ma-
nipulation techniques was applied if the anatomical location of
the fibroid was optimal on the T2w 3D planning images.
Manipulation techniques were indicated when the targeted uter-
ine fibroid was (partially) inaccessible or interposition of critical
structures was observed in the beam pathway. These manipula-
tion techniques were applied using two different protocols:
Protocol 1 (n = 20 treatments): the BRB maneuver which
included sequential applications of urinary bladder fill-
ing, rectal filling, and urinary bladder emptying [10].
Bladder filling was performed by manually squeezing a
plastic bag of saline connected to the side arm of a
clamped Foley catheter. The amount of urinary filling
ranged from 100 to 500 mL and was adjusted to patient
tolerance. The rectum was filled with multiple syringes
(60 mL) using a solution of ultrasound gel (30 mL) and
saline solution (30 mL) via a rectal catheter. The amount
of rectal filling ranged from 240 to 480 mL, based on
patient tolerance. To facilitate bladder emptying, natural
drainage was allowed by declamping the catheter. The
BRB maneuver required an additional 30 min.
Protocol 2 (n = 47 treatments): the 3-step modified ma-
nipulation protocol.
1. The BRBmaneuver with modified rectal filling in order to
ensure a consistent and greater anterior displacement;
compared with the above described BRB technique, the
rectum was not filled with ultrasound coupling gel alone,
but with a modified solution by adding 1 sachet (3.4 g) of
psyllium fibers (Metamucil®) to the 60-mL syringe. This
BRB manipulation moved the fibroid anteriorly or
displaced bowel loops (Fig. 2).
2. Trendelenburg position with bowel massage; patients
were positioned into the Trendelenburg position to move
the small bowel out of the pelvis (Fig. 3). Additionally,
abdominal massage was performed on both sides of the
lower abdomen with movements toward the upper abdo-
men. This technique was used when the uterine fibroid
was located ventrally (anteverted uterus) and the BRB
maneuver failed to succeed. The extra time spent on pa-
tient positioning was approximately 45 min.
3. Manual uterine manipulation (MUM): a retroverted posi-
tion of the uterus required manual repositioning into
anteflexion. To prepare for MUM, the urinary bladder
was filled with saline to prevent the interposition of bowel
loops during anteversion. Afterwards, we fixated the po-
sition of the uterus (Fig. 4) with rectal filling and/or the
use of a disposable plastic vaginal speculum (Bridea
Medical). The speculum was kept out of the beam path-
way to avoid potential interference in the ultrasonic ener-
gy field. When the uterine fibroid was located dorsally
(anteverted uterus) in the recto-sigmoid region (or when
the BRB maneuver failed to succeed), the operator used
the MUM method for repositioning of the uterine fibroid
itself (Fig. 4). On average, MUM required 15 min.
MR-HIFU treatment
MR-HIFU treatments were performed using a clinical HIFU
system (Sonalleve, V1, ProfoundMedical Inc.) integrated into
a 1.5-T MR scanner (Achieva; Philips Healthcare). Three ra-
diologists (R.v.d.H.; E.d.B.; M.v.t.V.t.K.) carried out all the
MR-HIFU procedures. Procedures were performed on an out-
patient basis under conscious sedation using propofol-fenta-
nyl. During MUM, a bolus of propofol was given to induce
moderate–deep sedation followed by supplemental boluses if
required. If necessary, Buscopan® (but ibrometo
escopolamina) was administered intravenously (multiple
times) to decrease bowel motion because the HIFU system
is sensitive to motion artifacts. Respiration-related motion ar-
tifacts were managed with breath hold instructions, especially
when the targeted fibroid was small (< 3 cm). Post-treatment
CE-T1w images were obtained to visualize the treatment re-
sult, called the non-perfused volume. The non-perfused vol-
ume (NPV) post-treatment was measured and the NPV% was
calculated (the NPV divided by the fibroid volume).
Results
Group 1 (n = 88) resulted in an ineligibility percentage of 53%
(47/88) based on the screening MRI (Table 1), of which 18%
(16/88) was due to the fibroids’ location (a retroverted uterus
or bowel interference).
Group 2 (n = 77) showed an ineligibility percentage of 25%
(19/77) of which 0% (0/77) was due to bowel interference or a
retroverted uterus (Table 1). Thus, our ineligibility rate due to
the location of the uterine fibroid decreased from 18 to 0%.
In total, we treated 67 women with 91 symptomatic uterine
fibroids. The baseline characteristics of the patients are shown
in Table 2. The mean NPV% immediately post-treatment was
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60.0 ± 35.9%. There were no complications or thermal inju-
ries to the bowel or uterus reported.
Group 1 (n = 20) received the following manipulation tech-
niques (Table 3): urinary filling only (n = 1), rectal filling only
Fig. 3 A symptomatic uterine fibroid (yellow star) located in the anterior
wall of the uterus of a patient. On the screeningMR images (a), there was
no interposition of bowel loops observed. However, on the MR-HIFU
treatment day, manipulation techniques were necessary to prevent treat-
ment failure due to the (unexpected) interposition of small bowel loops
(turquoise arrows). First, the BRB maneuver (b and c) was performed to
displace the bowel loops. In some cases, the bladder filling will only
cause an upwards movement of the uterus (c). Therefore, this patient
was placed into supine and Trendelenburg positions (d). Additionally,
abdominal massage was performed on both sides of the lower abdomen
with movements towards the upper abdomen (d). After 5 min, the patient
was returned in prone position and the MR images no longer showed
interposition of bowel loops (e). f Post-HIFU contrast-enhanced T1w
image. Specific treatment planning images are provided in the supple-
mental information
Fig. 2 The screening MR images are shown on the left (a and f) of two
different patients who underwent MR-HIFU therapy. On treatment day,
manipulation techniques were applied to achieve optimal patient position-
ing. The pre-treatment T2w 3D images (b) of the first patient demonstrat-
ed an increased distance between the fibroid (yellow star) and the abdom-
inal wall, contrary to our expectations based on the screening MRI (a). A
combination of bladder filling (c; purple dot) and rectal filling with saline
solution, ultrasound gel and psyllium fibers (d; green cross) moved the
fibroid anteriorly. Bowel interference was expected in the second patient,
based on the screening MR images of the targeted fibroid (f; yellow star).
To displace the bowel loops, the BRBmaneuver was usedwhich included
sequential applications of urinary bladder filling (g; purple dot), rectal
filling (h; green cross), and bladder emptying (i). e, j The immediate
post-HIFU contrast-enhanced T1w images. Specific treatment planning
images are provided in the supplemental information
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(n = 1), or a combination of urinary and rectal filling (n = 12).
This was necessary due to the following reasons (multiple
reasons in some cases): interposition of bowel loops (n = 9),
to decrease the distance (n = 3), to move the fibroid cranially
(n = 1), or a retroverted uterus (n = 1). In two cases, an abdom-
inal scar was present in the expected beam pathway; therefore,
a scar patch was used to prevent the risk of skin burns.
However, during the treatment, it appeared that a too large
portion of the ultrasound beam was reflected which resulted
in failed treatments because the required thermal dose could
not be delivered to the fibroid. Despite the use of the BRB
maneuver, still 20% of our treatments failed due to the inter-
position of bowel loops (Table 4). In these patients, no inter-
position of bowel loops was observed on the screening MR
images.
Group 2 (n = 47) received the following mitigation strate-
gies (Table 3): rectal filling only (n = 4), a combination of
urinary and rectal filling with psyllium fibers (n = 12), MUM
(n = 8), Trendelenburg position with bowel massage (n = 4),
extra gel pad (n = 1), and endo-rectal coil (n = 1). This was
necessary due to the following reasons (multiple reasons in
some cases): interposition of bowel loops (n = 15), to decrease
the distance (n = 10), BRB failure (n = 4), or a retroverted
uterus (n = 5). The extra gel pad was used once as an adjuvant
bowel repositioning technique because interposed bowel
Fig. 4 The screening MR images (a and e) of two different cases are
shown to illustrate the manual uterine manipulation (MUM) method. a
The screening MR image of a uterine fibroid (yellow star) located in the
retroverted uterus. To create an acoustic window forMR-HIFU treatment,
anteversion of the uterus was required since bladder and rectal filling was
not sufficient (b). TheMUMmethod was used to reposition the uterus (c).
In this case, rectal filling and a plastic speculum (blue arrowhead) were
used for fixation of the uterine position. A speculum is necessary when
the fibroid cannot be fixated with rectal filling only. e The screening MR
images of a retroverted uterus with a single pedunculated uterine fibroid
(yellow star). Bladder filling was performed to prepare for manual repo-
sitioning (f); this prevents the interposition of bowel loops during the
MUM method of the uterine fibroid. After anterior displacement of the
uterine fibroid, rectal filling was used for fixation and the bladder was
emptied (g), and the fibroid was accessible for MR-HIFU therapy. d, h
The immediate post-HIFU contrast-enhanced T1w images. Specific treat-
ment planning images are provided in the supplemental information
Table 1 Reasons for ineligibility of patients for MR-HIFU based on
screeningMR images: a comparison between twomanipulation treatment
protocols
Reason for ineligibility Group A: BRB
maneuver
protocol
(n = 88/165
screened)
Group B: 3-step
modified manipulation
protocol (n = 77/165
screened)
Subcutaneous fat layer > 4 cm 3 (3.4) 4 (5.2)
Fibroid size 3 (3.4) 2 (2.6)
> 10 fibroids 8 (2.4) 1 (1.3)
Adenomyosis (concomitant) 4 (4.5) 7 (9.1)
No enhancement on CE-T1WI 1 (1.1) 2 (2.6)
Large abdominal scar 1 (1.1) 0 (0.0)
Excessively high signal
intensity on T2WI
11 (12.5) 1 (1.3)
Uterus RVF 6 (6.8) 0 (0.0)
Fibroid’s location/interposition 10 (11.4) 0 (0.0)
Claustrophobia 0 (0.0) 1 (1.3)
Possible malignancy 0 (0.0) 1 (1.3)
Total ineligible 47/88 (53.4) 19/77 (24.7)
Data presented as n (%)
BRB, bladder filling, rectal filling, bladder emptying; CE-T1WI, contrast-
enhanced T1-weighted imaging; T2WI, T2-weighted imaging; RVF,
retroverted position of the uterus
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loops were seen in the sonication pathway cranially from the
uterine fibroid.
By implementing the 3-step modified manipulation proto-
col, our treatment failure rate due to the interposition of bowel
loops decreased from 20% (4/20) to 2% (1/47). Only 2%
(1/47) of the MR-HIFU treatments failed because the 3-step
modified manipulation protocol was not sufficient to provide
an unobstructed acoustic window on the fibroid (Table 4). In
this specific case, the fibroid was located in the recto-sigmoid
region while the uterus was already anteverted. Eventually,
this patient was treated successfully because an endo-rectal
coil filled with saline solution was inserted which caused an-
terior displacement of the uterine fibroid (Fig. 5).
Discussion
The aim of this study was to evaluate the effect of a 3-step
modified manipulation protocol developed by us to improve
the eligibility percentage and treatment failure rate of MRI-
HIFU for uterine fibroids.
After implementing our 3-step modified manipulation pro-
tocol, the location of the uterine fibroid on screening MR
images was no longer a reason for ineligibility which drasti-
cally improved our eligibility percentage. An eligibility per-
centage of 75% is one of the highest reported to date [1, 2].
Although Zaher et al reported that 74% of the patients in their
study was suitable for MR-HIFU, patients in their study with
large or multiple fibroids were not excluded and 38% required
two MR-HIFU sessions [7]. A more recently published study
also described the use of bowel interference mitigation strate-
gies and reported an eligibility percentage of 72% [7, 9]. With
more liberal inclusion criteria, MR-HIFU treatment can be
offered to the majority of the referred patients with symptom-
atic uterine fibroids.
Comparison of treatment failures due to unsuccessful ma-
nipulation between the two protocols showed a reduction of
18%, which is an important improvement from a clinical per-
spective. This result may be biased by the fact that a learning
curve (negatively) influenced our treatments in group 1 [13].
However, it is also plausible that the patients in group 2 were
more difficult manipulation cases because a difficult location of
the fibroid was no reason for exclusion. The learning curve also
coincided with the decision that not all Funaki type 3 fibroids
Table 2 Baseline patient characteristics
Characteristic
Age (years) 44.0 ± 7.0
BMI (kg/m2) 24.98 ± 3.56
Subcutaneous fat layer (cm) 2.16 ± 1.11
History of pregnancy Yes 41 (61.2)
No 26 (38.8)
History of prior medical treatment Yes 44 (65.7)
No 23 (34.3)
Abdominal scar present 12 (18.2)
Baseline tSSS 49.9 ± 16.3
Baseline tHRQL 57.5 ± 19.9
Uterine position Anteverted 55 (82.1)
Retroverted 12 (17.9)
Number of fibroids 1 27 (40.3)
2 14 (20.9)
3 13 (19.4)
4 4 (6.0)
5 4 (6.0)
> 5 5 (7.5)
Number of fibroids treated 1 56 (83.5)
2 4 (6.0)
3 5 (7.5)
4 1 (1.5)
5 1 (1.5)
Fibroid location (FIGO) Submucosal 24 (26.4)
Intramural 23 (25.3)
Submucosal 29 (31.9)
Hybrid 15 (16.5)
Funaki classification 1 8 (8.8)
2 74 (81.3)
3 9 (9.9)
Fibroid volume (cm3) 133.10 ± 207.06
Maximum diameter (cm) 5.78 ± 3.29
Data presented as mean ± standard deviation or n (%)
BMI, body mass index; tSSS, transformed Symptom Severity Score;
tHRQL, transformed Health-Related Quality of Life; FIGO, Fédération
Internationale de Gynécologie et d’Obstétrique
Table 3 Comparison of the manipulation techniques for MR-HIFU
treatments using the two different manipulation protocols
Manipulation
techniques
Group 1: BRB
maneuver
(n = 20/67)
Group 2: 3-step
modified manipulation
protocol (n = 47/67)
None 6 (30.0) 17 (36.2)
Manipulation with: 14 (70.0) 29 (61.7)
- Urinary filling 1 (5.0) 0 (0.0)
- Rectal filling 1 (5.0) 4 (8.5)
- BRB 12 (60.0) 12 (25.5)
- Trendelenburg +
bowel massage
0 (0.0) 4 (8.5)
- MUM 0 (0.0) 8 (17.0)
- Extra gel pad 0 (0.0) 1 (2.1)
- Endo-rectal coil 0 (0.0) 1 (2.1)
Data presented as n (%)
BRB, bladder filling, rectal filling, bladder emptying;MUM, manual uter-
ine manipulation
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were excluded in group 2. This decision, as expected, led to
more treatment failures due to inadequate heating. Dropping
this exclusion criterion negatively influenced the treatment fail-
ure rate in group 2. Despite all the abovementionedmore liberal
inclusion criteria, we still managed to reduce our overall treat-
ment failure rate and we eliminated the problem of bowel in-
terference (in a relatively high-volume experienced MR-HIFU
center).
To share our experience with the different manipulation
techniques applied in this study, we will discuss the details
of each approach further below.
To prevent the displaced bowel loops from moving down-
wards, maintenance of urinary bladder filling was sometimes
necessary. This is not desirable because a clamped Foley cath-
eter results in an upwards movement of the uterine fibroid due
to inflow of urine. This may lead to misregistration between
the real location of the fibroid and the treatment planning
images; this can be monitored by placing markers. To solve
this issue, renewed T2w planning images can be obtained in
between sonications, although this is lengthening the
procedure. However, the already performed sonications will
remain at their original (incorrect) position due to misregistra-
tion. This could lead to partially ablated fibroids, but develop-
ment of MR registration could overcome this problem, and
therefore enhance treatment efficacy.
In our experience, rectal filling with ultrasound gel only
was suboptimal because the gel slowly migrates proximally
which led to displacement of the uterine fibroid during the
therapy. Park et al reported that the rectal distention was usu-
ally maintained for almost an hour [10], but the duration of the
MR-HIFU therapy is generally a couple of hours. Therefore,
psyllium fibers were added to the fluid used for rectal filling.
Psyllium fibers have been widely used for radiological exam-
inations of the bowel as a water-soluble contrast agent [14].
The adjusted rectal filling applied firm pressure during the
total length of theMR-HIFU procedure. Moreover, the uterine
fibroid was displaced more anteriorly when psyllium fibers
were used. Compared with Park et al, the total amount of
rectal filling was much larger, which our patients tolerated
easily without complaining of a sense of defecation or consti-
pation afterwards [10]. Post-treatment, patients were
instructed to drink lots of water to prevent constipation from
the psyllium fibers.
To the best of our knowledge, the MUM method has not
been described elsewhere. Pulanic et al did report that vaginal
pessary placement may help in uterine repositioning to enable
safe ablation [15]. Jeong et al demonstrated the feasibility of
an uterine elevator device to change the position of the uterus,
but this requires aMRI-compatible uterine manipulator device
which must be sutured in the cervix pre-treatment [16].
Compared with the uterine elevator, MUM has the advantage
of being non-invasive and cost free. Another advantage of
MUM was the provided real-time haptic feedback during
manual repositioning. With other manipulation techniques,
new MR images have to be obtained to visualize the effect.
Logically, MUM was the fastest manipulation method. Post-
HIFU, patients did not remember the manipulation procedure
Table 4 Reasons for treatment failures compared between the two
manipulation protocols for MR-HIFU therapy
Reason for failure Group 1: BRB
maneuver (n = 20/67)
Group 2: 3-step
modified manipulation
protocol (n = 47/67)
Interposition 4 (20.0) 1 (2.1)
Scar patch 2 (10.0) 0 (0.0)
Motion artifacts 1 (5.0) 0 (0.0)
Inadequate heating 1 (5.0) 3 (6.4)
Patient discomfort 0 (0.0) 1 (2.1)
Device malfunction 0 (0.0) 1 (2.1)
Total 8/20 (40.0) 6/47 (12.8)
Data presented as n (%)
BRB, bladder filling, rectal filling, bladder emptying
Fig. 5 Pre-treatment MR images showed a uterine fibroid located on the
posterior wall of an anteverted uterus (a). The image on the left shows the
position of the fibroid without manipulation (yellow star). The BRB and
MUM techniques both failed to move the uterine fibroid anteriorly (b).
Therefore, a rectal balloon device (prostate endo-rectal coil; orange
square) was inserted (c). The endo-rectal coil was filled with water and
surrounded by the ultrasound gel. The inflatable endo-rectal device
caused anterior displacement of the uterine fibroid which is now accessi-
ble for MR-HIFU treatment. d The post-HIFU contrast-enhanced T1w
image. Specific treatment planning images are provided in the supple-
mental information
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itself due to the moderate–deep sedation with propofol.
Importantly, the renewed position of the uterine fibroid was
maintained during the complete MR-HIFU procedure. This is
probably due to a combination of the effect of gravity while in
the prone position and the fixation with rectal filling and/or a
plastic speculum.
Miscellaneous bowel interference mitigation strategies
have been described such as the use of a degassed water bal-
loon and a wedged gel pad [17–19]. In this work, we share our
experience with the Trendelenburg maneuver and bowel mas-
sage. Both were the most time consuming of all different
manipulation techniques since the patient must be turned into
supine position; but in some cases, it may be the only option to
prevent treatment failure. Therefore, we only performed this
step when the previous options failed.
In one patient, the current 3-step modified manipulation
protocol failed to create an appropriate acoustic window.
Nonetheless, this patient was treated successfully by using
an endo-rectal coil for anterior displacement of the uterine
fibroid. The use of an endo-rectal coil is not a standard proce-
dure at our center since it is expensive and sensitive to arti-
facts, but it was helpful in treating this large fibroid located in
the recto-sigmoid region. The use of another endo-rectal de-
vice without a coil, but with a cooling system, has been pre-
viously described for MR-HIFU prostate treatment with the
TULSA-PRO system [20]. However, this device is not inflat-
able and may therefore not provide enough pressure to move
the fibroid anteriorly. Development of an endo-rectal balloon
device with a cooling system would be the ideal tool for ma-
nipulation since it could also potentially protect the bowel
from thermal damage. Thermal complications such as bowel
perforation are very rare but have been reported in literature
after HIFU of uterine fibroids [21–23]. Development of an
endo-rectal balloon device (without coil or cooling) would
be a more cost-effective solution.
In our opinion, adequate patient preparation is key for a
successful MR-HIFU treatment. Technological tools have
been developed to overcome the issue of bowel interference
such as beam-shaping and angulation, but these tools further
limit the focal depth and power of the systemwhich often lead
to partially unreachable fibroids or lengthening of the proce-
dure [8]. Despite the additional time necessary before sonicat-
ing, optimal patient positioning reduced the risk for treatment
failure.
A limitation of this work was the relatively small sample
size and the single-center design. Dissemination and imple-
mentation of the 3-step modified manipulation protocol to
other institutions in clinical practice will be challenging.
Moreover, a learning curve effect complicated the evaluation
of our results which may have distorted the comparison be-
tween manipulation protocols. Therefore, a larger multi-center
cohort study should be conducted in the future to follow-up on
implementation and the results of the 3-step modified manip-
ulation protocol.
Conclusions
Implementation of a newly developed 3-step modified manip-
ulation protocol increased the eligibility percentage and re-
duced the treatment failure rate for treatment of uterine fi-
broids with MR-HIFU.
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